Breast-conserving therapy may be option for multiple breast lesions

Elacestrant shows improved PFS in ER-positive/HER2-negative mBC

T-DXd demonstrates high levels of efficacy in patients with HER2+ unresectable and/or mBC previously treated with T-DM1

Breast cancer patients who interrupted endocrine therapy to pursue pregnancy did not have worse short-term recurrence rates

Comment: POLAR gene profile can identify which patients can safely avoid radiation therapy after breast-conserving surgery

Updates from TAILORx and RxPONDER: Implications for practice

Interruption of endocrine therapy in young breast cancer patients does not increase the risk of short-term relapse

Genetic profiling identifies patients who can omit radiation therapy after breast-conserving surgery

Longest follow-up of patients with early breast cancer shows radiotherapy does not improve survival after 30 years

Optimisation of supportive, palliative and end of life care

What is required to advance data ethics, data sharing, and Open Science across LMICs

A genomic assay may predict long-term prognosis in premenopausal patients with HR+ early-stage breast cancer